Gossamer Bio Inc

Biotech Stocks Healthcare Stocks

$11.63

+0.35 (+3.10%)

As of Sep 22, 2:46 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 9 64%

Hold 4 29%

Sell 1 7%

Price Target

Analyst Price Target +135.7% upside

Low Target $18.46

Average Target $27.41

High Target $44.08

Current Price $11.63

Current
$11.63

Target
$27.41

$18.46 $27.41 avg $44.08

Scenario Analysis

Bear Case

$18.46

58.7%

Low target

Base Case

$27.41

+135.7%

Avg target

Bull Case

$44.08

+279.0%

High target

Risk/Reward

4.8x

Highly favorable

Price in Context

52-Week High

$309.60

-96.2% from high

52-Week Low

$9.10

+27.8% from low

Target vs 52W High

$27.41

-91.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%